Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements

Abstract Treatment based on immune checkpoint blockade has revolutionized cancer therapy. Despite the remarkable success achieved and the preclinical development of multiple checkpoint inhibitors targeting other checkpoints, only antibodies targeting the PD-1/PD-L1 axis and CTLA-4 have been approved...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alejandra Martínez-Pérez (Autor), Rocío Granda-Díaz (Autor), Candelaria Aguilar-García (Autor), Christian Sordo-Bahamonde (Autor), Segundo Gonzalez (Autor)
Formato: Libro
Publicado: BMC, 2024-10-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible